ERBB2 and ductal breast carcinoma in situ: In the subset of 17 cases without NAC involvement, only 1 (6%) invasive cancer exhibited HER2 overexpression (P<0.001); however, both the associated DCIS and the corresponding NDc were HER2-negative.